KROS NASDAQ
Keros Therapeutics, Inc.
1W: +2.1%
1M: -1.9%
3M: -30.7%
YTD: -39.5%
1Y: -20.6%
3Y: -75.8%
5Y: -77.0%
$11.19
-0.03 (-0.27%)
Weekly Expected Move ±6.9%
$9
$10
$10
$11
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$33M
Revenue
-84.5% YoY
$-85M
Net Income
-2121.5% YoY
$-58M
Free Cash Flow
-234.5% YoY
-9.8%
Gross Margin
-7051.0%
Op. Margin
-6459.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-19.5%
ROA-17.9%
ROIC-267.4%
Valuation
P/E-4.9
P/B1.5
EV/EBITDA-1.5
Leverage
Debt/Equity0.06
Current Ratio15.45
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z5.39
Beneish M650.77